600422 Stock Overview
KPC Pharmaceuticals, Inc, a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
KPC Pharmaceuticals,Inc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.72 |
| 52 Week High | CN¥26.09 |
| 52 Week Low | CN¥15.18 |
| Beta | 0.35 |
| 1 Month Change | 7.83% |
| 3 Month Change | 27.64% |
| 1 Year Change | -2.15% |
| 3 Year Change | 149.40% |
| 5 Year Change | 118.67% |
| Change since IPO | 409.31% |
Recent News & Updates
Shareholder Returns
| 600422 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 3.3% | 5.6% | 3.1% |
| 1Y | -2.2% | -11.0% | -13.1% |
Return vs Industry: 600422 exceeded the CN Pharmaceuticals industry which returned -11% over the past year.
Return vs Market: 600422 exceeded the CN Market which returned -13.1% over the past year.
Price Volatility
| 600422 volatility | |
|---|---|
| 600422 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 7.5% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 600422 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600422's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1951 | 5,051 | Xianggang Zhong | www.kpc.com.cn |
KPC Pharmaceuticals, Inc, a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug.
KPC Pharmaceuticals,Inc Fundamentals Summary
| 600422 fundamental statistics | |
|---|---|
| Market cap | CN¥17.20b |
| Earnings (TTM) | CN¥432.35m |
| Revenue (TTM) | CN¥7.65b |
39.8x
P/E Ratio2.2x
P/S RatioIs 600422 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600422 income statement (TTM) | |
|---|---|
| Revenue | CN¥7.65b |
| Cost of Revenue | CN¥4.32b |
| Gross Profit | CN¥3.33b |
| Other Expenses | CN¥2.90b |
| Earnings | CN¥432.35m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.57 |
| Gross Margin | 43.54% |
| Net Profit Margin | 5.65% |
| Debt/Equity Ratio | 15.3% |
How did 600422 perform over the long term?
See historical performance and comparison